Historical shareholding details of T. Rowe Price Health Sciences Fund holdings in Celldex Therapeutics Inc. (CLDX)

Monthly changes of T. Rowe Price Health Sciences Fund shareholding in Celldex Therapeutics Inc. over the previous months

Month	Name	Total no. shares held	Percent Holding
Month	Name	Total no. shares held	Percent Holding
Jul 31, 2025	T. Rowe Price Health Sciences Fund	645,941	0.97%

Jun 30, 2025	T. Rowe Price Health Sciences Fund	750,770	1.13%

Mar 31, 2025	T. Rowe Price Health Sciences Fund	470,986	0.71%

Feb 28, 2025	T. Rowe Price Health Sciences Fund	573,846	0.86%

Jan 31, 2025	T. Rowe Price Health Sciences Fund	603,446	0.91%

Dec 31, 2024	T. Rowe Price Health Sciences Fund	663,469	1.00%

Nov 30, 2024	T. Rowe Price Health Sciences Fund	665,223	1.00%

Oct 31, 2024	T. Rowe Price Health Sciences Fund	682,679	1.03%

Sep 30, 2024	T. Rowe Price Health Sciences Fund	761,430	1.15%

Aug 31, 2024	T. Rowe Price Health Sciences Fund	787,061	1.19%

Jun 30, 2024	T. Rowe Price Health Sciences Fund	1,106,747	1.67%

Mar 31, 2024	T. Rowe Price Health Sciences Fund	1,351,793	2.05%

Dec 31, 2023	T. Rowe Price Health Sciences Fund	297,616	0.45%

Sep 30, 2023	T. Rowe Price Health Sciences Fund	333,686	0.61%

Jun 30, 2023	T. Rowe Price Health Sciences Fund	343,157	0.73%

Mar 31, 2023	T. Rowe Price Health Sciences Fund	521,045	1.10%